Difficulty: Medium
Average Score: 85%
Practice
Which of the following drugs is a 5-lipoxygenase (5-LOG) inhibitor?
Correct answer
B
Rationale
In pharmacology, understanding the mechanisms of action of different drugs is essential. In this case, the correct answer is B) Zileuton (Zyflo), which is a 5-lipoxygenase (5-LO) inhibitor. 5-LO is an enzyme involved in the production of leukotrienes, which are inflammatory mediators. By inhibiting 5-LO, Zileuton helps reduce inflammation in conditions like asthma.
Now, let's discuss why the other options are incorrect:
A) Ibuprofen - Ibuprofen is a nonsteroidal anti-inflammatory drug (NSAID) that works by inhibiting cyclooxygenase (COX) enzymes, not 5-LO.
C) Metamizole (Analgin) - Metamizole is a non-opioid analgesic with antipyretic properties, but it does not inhibit 5-LO.
D) Diclofenac - Diclofenac is another NSAID that inhibits COX enzymes, not 5-LO.
Educational context:
Understanding the specific mechanisms of action of different drugs helps pharmacology students make informed decisions in clinical practice. Knowing that Zileuton targets 5-LO can guide healthcare providers in choosing the right medication for patients with conditions where leukotrienes play a significant role in pathology, such as asthma or inflammatory disorders. This knowledge also aids in preventing adverse drug interactions and optimizing therapeutic outcomes.
Now, let's discuss why the other options are incorrect:
A) Ibuprofen - Ibuprofen is a nonsteroidal anti-inflammatory drug (NSAID) that works by inhibiting cyclooxygenase (COX) enzymes, not 5-LO.
C) Metamizole (Analgin) - Metamizole is a non-opioid analgesic with antipyretic properties, but it does not inhibit 5-LO.
D) Diclofenac - Diclofenac is another NSAID that inhibits COX enzymes, not 5-LO.
Educational context:
Understanding the specific mechanisms of action of different drugs helps pharmacology students make informed decisions in clinical practice. Knowing that Zileuton targets 5-LO can guide healthcare providers in choosing the right medication for patients with conditions where leukotrienes play a significant role in pathology, such as asthma or inflammatory disorders. This knowledge also aids in preventing adverse drug interactions and optimizing therapeutic outcomes.